Okoro Chukwuemeka Ogbonna

Dr. Okoro Chukwuemeka Ogbonna

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2024 in Molecules
Verified
Journal Article
Open access
PDF file
CEChinedu Ogbonnia Egwu
Chinedu Ogbonnia Egwu
CAChinyere Aloke
Chinyere Aloke
KOKenneth T. Onwe
Kenneth T. Onwe
CUChukwunalu Igbudu Umoke
Chukwunalu Igbudu Umoke
JNJoseph Alo Nwafor
Joseph Alo Nwafor
OOOkoro Chukwuemeka Ogbonna
Okoro Chukwuemeka Ogbonna
There is a myriad of diseases that plague the world ranging from infectious, cancer and other chronic diseases with varying interventions. However, the dynamism of causative agents of infectious diseases and incessant mutations accompanying other forms of chronic diseases like cancer, have worsened the treatment outcomes. These factors often lead to treatment failure via different drug resistance mechanisms. More so, the cost of developing newer drugs is huge. This underscores the need for a paradigm shift in the drug delivery approach in order to achieve desired treatment outcomes. There is intensified research in nanomedicine, which has shown promises in improving the therapeutic outcome of drugs at preclinical stages with increased efficacy and reduced toxicity. Regardless of the huge benefits of nanotechnology in drug delivery, challenges such as regulatory approval, scalability, cost implication and potential toxicity must be addressed via streamlining of regulatory hurdles and increased research funding. In conclusion, the idea of nanotechnology in drug delivery holds immense promise for optimizing therapeutic outcomes. This work presents opportunities to revolutionize treatment strategies, providing expert opinions on translating the huge amount of research in nanomedicine into clinical benefits for patients with resistant infections and cancer.

29 June 2025 in Journal of Biological Research
Verified
Journal Article
Open access
PDF file
OOOkoro Chukwuemeka Ogbonna
Okoro Chukwuemeka Ogbonna
Turmeric is one of the powerful gift of nature to man to treat diseases. The therapeutic and pharmacological uses of different bioactive components of turmeric are been slowly revealed. Flavonoid belongs to the human diet’s phenolic phytochemical compounds found in nature. This study analyzed the flavonoid composition of turmeric using standard method to reveal the presence and percentage composition of different flavonoids found in turmeric cultivated in Ebonyi State. The results revealed the presence of gallic acid (4.028), p-coumaric acid (1.464), ferrulic acid (7.949), rutin (5.88), quercetin (14.322) and kampferol (10.812 ppm). The high quantity of flavonoid in turmeric renders it a good plant in herbal medicine. This may account for the folkloric use of turmeric plant by miners in Ebonyi State.